000			03397nam a2200409 i 4500
999			_c99913 _d99913 _x1
001			99913
003			ES-MaUEC
005			20230110040156.0
006			a||||fo|||| 00| 0
007			cr nn 008aamaa
008			180328s2018 gw | o |||| 0|eng d
020			_a9783319687902
024	7		_a10.1007/978-3-319-68790-2 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
041	0		_aeng
050		4	_aRL97 _b2018 EB
245	0	0	_aSkin Diseases in the Immunosuppressed _cedited by Oscar R. Colegio
264		1	_aCham, Switzerland _bSpringer International Publishing _c2018
300			_a1 recurso en línea (X, 211 páginas) _b49 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aThe Immune System: Structure, Function, and Roles in Skin Disease.- Skin Diseases in Primary Immunodeficiencies -- Skin Diseases Associated with HIV Disease -- Benign Cutaneous Eruptions After Transplantation.- Cutaneous Malignancies in Solid Organ Transplant Recipients.- Skin Diseases Associated with Stem Cell Transplantation.- Skin Cancers Associated With Lymphoid Malignancies.- Skin Diseases Associated with Biologic Therapies.- Virally Induced Cancers.- Immunosenescence and Cutaneous Malignancies.  .
520	3		_aIn this book, expert dermatologists review state of the art knowledge concerning the clinical presentation and management of cutaneous diseases that develop in immunosuppressed individuals, including transplant recipients, those with primary immunodeficiencies, and HIV sufferers. Throughout the book, correlations are made with iatrogenic, primary, and acquired immunodeficiencies. A major aim is to enable dermatologists to identify the specific immunosuppressant responsible for a specific adverse effect, whether benign or malignant, in patients receiving a complex medication regimen in the setting of transplantation. Further, the book will help the dermatologist to distinguish the cutaneous adverse effects of antiviral agents from effects arising directly from advancing HIV disease. Recognition of the cutaneous manifestations of often less common primary immunodeficiencies will also be emphasized. A final goal is to improve patient outcomes by providing dermatologists with treatment strategies for skin disease arising in the immunosuppressed state. This book will be invaluable for a broad audience, from practicing dermatologists to medical and dermatology residents.
988			_aSpringer_Medicine_2018
650		7	_2embne _9168912 _aPiel _xEnfermedades _xAspectos inmunológicos
650		7	_2embne _9142010 _aEnfermedades inmunológicas
700	1		_aColegio, Oscar R. _eeditor literario _0http://id.loc.gov/authorities/names/n2018187191 _0http://viaf.org/viaf/9153773485661431641
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996
776	0	8	_iEdición impresa: _z9783319687889
776	0	8	_iEdición impresa: _z9783319687896
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-68790-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b03/2020 _dz _eb _zSI